CoreCap Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$928 Sell
160
-251
-61% -$1.84K ﹤0.01% 2676
2026
Q2
$3.48K Hold
411
– – ﹤0.01% 2382
2026
Q1
$2.24K Hold
411
– – ﹤0.01% 2383
2025
Q4
$2.88K Hold
411
– – ﹤0.01% 2372
2025
Q3
$3.18K Sell
411
-1,300
-76% -$10.1K ﹤0.01% 2285
2025
Q2
$14.9K Sell
1,711
-125
-7% -$906 ﹤0.01% 1711
2025
Q1
$14.6K Sell
1,836
-300
-14% -$3.04K ﹤0.01% 1665
2024
Q4
$19.4K Buy
2,136
+51
+2% +$492 ﹤0.01% 1549
2024
Q3
$19.1K Hold
2,085
– – ﹤0.01% 1582
2024
Q2
$20.4K Sell
2,085
-800
-28% -$9.8K ﹤0.01% 892
2024
Q1
$43.6K Buy
+2,885
New +$52.4K ﹤0.01% 1172
2022
Q4
$1.51K Buy
+64
New +$1.73K ﹤0.01% 1990
2022
Q3
– Sell
-529
Closed -$18K – 1913
2022
Q2
$18K Buy
+529
New +$22.5K ﹤0.01% 1289
2022
Q1
– Sell
-103
Closed -$9K – 1916
2021
Q4
$9K Buy
+103
New +$12.3K ﹤0.01% 1598

Other funds holding TDOC

CoreCap Advisors's TDOC Position: Q3 2026 in Review

CoreCap Advisors reduced its Teladoc Health (TDOC) stake by 61% in Q3 2026, selling an estimated $1.84K and leaving 160 shares worth $928. The position accounts for ﹤0.01% of the portfolio, ranked #2676.

CoreCap Advisors first reported a position in TDOC in Q4 2021 and has held it in 14 quarters since. The position peaked at $43.6K in Q1 2024. 48 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.

  • CoreCap Advisors held 160 shares of Teladoc Health worth $928 as of Q3 2026.
  • CoreCap Advisors sold 251 Teladoc Health shares in Q3 2026, an estimated $1.84K.
  • Teladoc Health made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2676 holding.
  • CoreCap Advisors first reported a position in Teladoc Health in Q4 2021 and has held it in 14 quarters since.
  • CoreCap Advisors's Teladoc Health position peaked at $43.6K in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.